ASND
Closed
Ascendis Pharma As
172.
-1 (-0.58%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 172.6
Day's Range: 167.515 - 173.7
Send
sign up or login to leave a comment!
When Written:
107.22
Ascendis Pharma AS is a biopharmaceutical company that specializes in developing innovative therapies for rare diseases. The company was founded in 2007 and is headquartered in Copenhagen, Denmark, with additional offices in the United States and Germany.
Ascendis Pharma's proprietary technology platform, TransCon, is designed to enhance the pharmacokinetic properties of therapeutic proteins and peptides, allowing for less frequent dosing and improved efficacy. The company's pipeline includes several product candidates in various stages of development for rare endocrine diseases, including growth hormone deficiency, hypoparathyroidism, and achondroplasia.
In 2020, Ascendis Pharma received FDA approval for its lead product candidate, TransCon hGH, for the treatment of pediatric growth hormone deficiency. The company has also entered into partnerships with pharmaceutical companies such as Sanofi and Roche to develop and commercialize its product candidates.
Ascendis Pharma is publicly traded on the Nasdaq stock exchange under the ticker symbol "ASND."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Ascendis Pharma's proprietary technology platform, TransCon, is designed to enhance the pharmacokinetic properties of therapeutic proteins and peptides, allowing for less frequent dosing and improved efficacy. The company's pipeline includes several product candidates in various stages of development for rare endocrine diseases, including growth hormone deficiency, hypoparathyroidism, and achondroplasia.
In 2020, Ascendis Pharma received FDA approval for its lead product candidate, TransCon hGH, for the treatment of pediatric growth hormone deficiency. The company has also entered into partnerships with pharmaceutical companies such as Sanofi and Roche to develop and commercialize its product candidates.
Ascendis Pharma is publicly traded on the Nasdaq stock exchange under the ticker symbol "ASND."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!